| ISIN | CH0389550945 |
|---|---|
| Valor Number | 38955094 |
| Bloomberg Global ID | UBSSPLW SW |
| Fund Name | UBS (CH) Investment Fund - Equities Switzerland Leader Index A-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Bonds |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | ... |
| Peculiarities |
| Current Price * | 160.41 CHF | 28.10.2025 |
|---|---|---|
| Previous Price * | 162.18 CHF | 27.10.2025 |
| 52 Week High * | 165.57 CHF | 03.03.2025 |
| 52 Week Low * | 136.85 CHF | 09.04.2025 |
| NAV * | 160.41 CHF | 28.10.2025 |
| Issue Price * | 160.41 CHF | 28.10.2025 |
| Redemption Price * | 160.41 CHF | 28.10.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,039,562,728 | |
| Unit/Share Assets *** | 120,957,415 | |
| Trading Information SIX | ||
| YTD Performance | +8.17% |
31.12.2024 - 28.10.2025
31.12.2024 28.10.2025 |
|---|---|---|
| 1 month | +2.62% |
29.09.2025 - 28.10.2025
29.09.2025 28.10.2025 |
| 3 months | +1.67% |
28.07.2025 - 28.10.2025
28.07.2025 28.10.2025 |
| 6 months | +4.23% |
28.04.2025 - 28.10.2025
28.04.2025 28.10.2025 |
| 1 year | +3.80% |
28.10.2024 - 28.10.2025
28.10.2024 28.10.2025 |
| 2 years | +31.47% |
30.10.2023 - 28.10.2025
30.10.2023 28.10.2025 |
| 3 years | +34.73% |
28.10.2022 - 28.10.2025
28.10.2022 28.10.2025 |
| 5 years | +55.69% |
28.10.2020 - 28.10.2025
28.10.2020 28.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 9.24% | |
|---|---|---|
| Nestle SA | 9.11% | |
| Novartis AG Registered Shares | 9.03% | |
| Roche Holding AG | 8.89% | |
| Swiss Re AG | 4.81% | |
| Compagnie Financiere Richemont SA Class A | 4.67% | |
| ABB Ltd | 4.64% | |
| Zurich Insurance Group AG | 4.57% | |
| Lonza Group Ltd | 4.12% | |
| Holcim Ltd | 3.97% | |
| Last data update | 30.09.2025 | |
| TER | 0.19% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.30% |
| Ongoing Charges *** | 0.19% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |